Brief: Gensight Biologics' GS030 Optogenetic Treatment Shows Promising Results In Nature Report
May 25 (Reuters) - GENSIGHT BIOLOGICS SA SIGHT.PA :
* ANNOUNCES NATURE MEDICINE CASE REPORT SHOWING VISUAL
RECOVERY
AFTER GS030 OPTOGENETIC TREATMENT
Source text for Eikon: ID:nBw1RkhMqa
Further company coverage: SIGHT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))
Recent news on Gensight Biologics SA
See all newsHealth Rounds: Blindness treatment based on Nobel-winning research shows promise
France's GenSight Biologics H1 net loss widens on higher R&D expenses
Brief: GenSight Biologics H1 Net Income EUR -10.3 Million
France's GenSight Biologics 2025 net loss narrows on reduced R&D spending
Brief: GenSight Biologics FY EPS EUR -0.08